Table 2.

Ongoing clinical trials.

NCT	Trial name	Angiosarcoma	Enrollment status	Preliminary data
NCT04784247	Lenvatinib and Pembrolizumab in People with advanced soft tissue Sarcoma	Includes experimental arm for vascular sarcomas (including angiosarcoma and epithelioid hemangioendothelioma)	Recruiting	Ongoing
NCT04668300	Oleclumab and Durvalumab for the treatment of recurrent, refractory, or metastatic sarcoma (DOSa)	Includes patients with metastatic angiosarcoma, recurrent angiosarcoma	Recruiting (estimated enrollment of 75 participants)	Ongoing
NCT03069378	A study of Talimogene Laherparepvec (T-VEC) in Combination with Pembrolizumab in Patients with metastatic and/or locally advanced Sarcoma	Includes patients with sarcoma, epithelioid sarcoma, and cutaneous angiosarcoma	Recruiting (estimated enrollment of 50 patients)	See above
NCT04339738	Testing the addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma	Skin angiosarcoma, skin radiation-related angiosarcoma, visceral angiosarcoma	Recruiting (estimated enrollment of 90 participants)	Ongoing